FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119962057> ?p ?o ?g. }

• W3119962057 endingPage "134" @default.
• W3119962057 startingPage "127" @default.
• W3119962057 abstract "Desde el inicio de la pandemia por el virus SARS-CoV2 la Sociedad Española de Neurología (SEN) creó un registro de afectación neurológica para informar al neurólogo clínico. Las encefalopatías y encefalitis fueron una de las complicaciones más descritas. Analizamos las características de las mismas. Estudio descriptivo retrospectivo, observacional multicéntrico, de pacientes con sintomatología compatible con encefalitis o encefalopatía, introducidos en el Registro SEN COVID-19 desde el 17 de marzo hasta el 6 de junio de 2020. Se han registrado 232 casos con síntomas neurológicos, 51 casos de encefalopatía/encefalitis (21,9%). Ningún paciente era trabajador sanitario. Los síndromes más frecuentes fueron: cuadro confusional leve-moderado (33%) y encefalopatía grave o coma (9,8%). El tiempo medio entre el inicio de la infección y la clínica neurológica fue de 8,02 días. Punción lumbar en el 60,8% de pacientes; solo hubo un caso con PCR positiva. Resonancia craneal en el 47% de los pacientes (alterada en el 7,8% de ellos). Se realizó electroencefalograma en el 41,3% de los casos (alterado en el 61,9% de los mismos). Las encefalopatías y encefalitis son dos de las complicaciones más frecuentes descritas en el SEN COVID-19. Más de un tercio de los pacientes presentó un cuadro de síndrome confusional leve o moderado. El tiempo medio de aparición de la sintomatología neurológica desde el inicio de la infección fue de 8 días (hasta 24 h antes en mujeres que en hombres). El electroencefalograma fue la prueba más sensible en estos pacientes, encontrando muy pocos casos con alteraciones en las pruebas de neuroimagen. Todos los pacientes que recibieron tratamiento con bolos de corticoides o inmunoglobulinas tuvieron una evolución favorable. Since the beginning of the COVID-19 pandemic, the Spanish Society of Neurology has run a registry of patients with neurological involvement for the purpose of informing clinical neurologists. Encephalopathy and encephalitis were among the most frequently reported complications. In this study, we analyse the characteristics of these complications. We conducted a retrospective, descriptive, observational, multicentre study of patients with symptoms compatible with encephalitis or encephalopathy, entered in the Spanish Society of Neurology's COVID-19 Registry from 17 March to 6 June 2020. A total of 232 patients with neurological symptoms were registered, including 51 cases of encephalopathy or encephalitis (21.9%). None of these patients were healthcare professionals. The most frequent syndromes were mild or moderate confusion (33%) and severe encephalopathy or coma (9.8%). The mean time between onset of infection and onset of neurological symptoms was 8.02 days. Lumbar puncture was performed in 60.8% of patients, with positive PCR results for SARS-CoV-2 in only one case. Brain MRI studies were performed in 47% of patients, with alterations detected in 7.8% of these. EEG studies were performed in 41.3% of cases, detecting alterations in 61.9%. Encephalopathy and encephalitis are among the complications most frequently reported in the registry. More than one-third of patients presented mild or moderate confusional syndrome. The mean time from onset of infection to onset of neurological symptoms was 8 days (up to 24 hours earlier in women than in men). EEG was the most sensitive test in these patients, with very few cases presenting alterations in neuroimaging studies. All patients treated with boluses of corticosteroids or immunoglobulins progressed favourably." @default.
• W3119962057 created "2021-01-18" @default.
• W3119962057 creator A5016697110 @default.
• W3119962057 creator A5017789220 @default.
• W3119962057 creator A5021160657 @default.
• W3119962057 creator A5021943242 @default.
• W3119962057 creator A5031178848 @default.
• W3119962057 creator A5037814142 @default.
• W3119962057 creator A5039437208 @default.
• W3119962057 creator A5040861018 @default.
• W3119962057 creator A5043896532 @default.
• W3119962057 creator A5044278014 @default.
• W3119962057 creator A5057833853 @default.
• W3119962057 creator A5057930986 @default.
• W3119962057 creator A5088209711 @default.
• W3119962057 creator A5090109122 @default.
• W3119962057 creator A5091509377 @default.
• W3119962057 date "2021-03-01" @default.
• W3119962057 modified "2023-10-16" @default.
• W3119962057 title "Encefalopatías y encefalitis durante la infección aguda por SARS-CoV2. Registro de la Sociedad Española de Neurología SEN COVID-19" @default.
• W3119962057 cites W2961171977 @default.
• W3119962057 cites W3001118548 @default.
• W3119962057 cites W3007201727 @default.
• W3119962057 cites W3011147220 @default.
• W3119962057 cites W3013177246 @default.
• W3119962057 cites W3013270768 @default.
• W3119962057 cites W3013398803 @default.
• W3119962057 cites W3013587223 @default.
• W3119962057 cites W3014310029 @default.
• W3119962057 cites W3015925195 @default.
• W3119962057 cites W3016124786 @default.
• W3119962057 cites W3016127017 @default.
• W3119962057 cites W3016367228 @default.
• W3119962057 cites W3017018770 @default.
• W3119962057 cites W3017156525 @default.
• W3119962057 cites W3017441365 @default.
• W3119962057 cites W3018668230 @default.
• W3119962057 cites W3018857106 @default.
• W3119962057 cites W3019953082 @default.
• W3119962057 cites W3020237904 @default.
• W3119962057 cites W3020561822 @default.
• W3119962057 cites W3021491427 @default.
• W3119962057 cites W3024635505 @default.
• W3119962057 cites W3024782611 @default.
• W3119962057 cites W3024888449 @default.
• W3119962057 cites W3025616849 @default.
• W3119962057 cites W3025947666 @default.
• W3119962057 cites W3026093247 @default.
• W3119962057 cites W3026174293 @default.
• W3119962057 cites W3028477247 @default.
• W3119962057 cites W3029083804 @default.
• W3119962057 cites W3031033561 @default.
• W3119962057 cites W3033451620 @default.
• W3119962057 cites W3033609484 @default.
• W3119962057 cites W3034422573 @default.
• W3119962057 cites W3034492260 @default.
• W3119962057 cites W3035880340 @default.
• W3119962057 cites W3036631414 @default.
• W3119962057 cites W3037507088 @default.
• W3119962057 cites W3041948228 @default.
• W3119962057 cites W3044800185 @default.
• W3119962057 cites W3045338721 @default.
• W3119962057 cites W3046450968 @default.
• W3119962057 doi "https://doi.org/10.1016/j.nrl.2020.11.013" @default.
• W3119962057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7877217" @default.
• W3119962057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33549369" @default.
• W3119962057 hasPublicationYear "2021" @default.
• W3119962057 type Work @default.
• W3119962057 sameAs 3119962057 @default.
• W3119962057 citedByCount "15" @default.
• W3119962057 countsByYear W31199620572021 @default.
• W3119962057 countsByYear W31199620572022 @default.
• W3119962057 countsByYear W31199620572023 @default.
• W3119962057 crossrefType "journal-article" @default.
• W3119962057 hasAuthorship W3119962057A5016697110 @default.
• W3119962057 hasAuthorship W3119962057A5017789220 @default.
• W3119962057 hasAuthorship W3119962057A5021160657 @default.
• W3119962057 hasAuthorship W3119962057A5021943242 @default.
• W3119962057 hasAuthorship W3119962057A5031178848 @default.
• W3119962057 hasAuthorship W3119962057A5037814142 @default.
• W3119962057 hasAuthorship W3119962057A5039437208 @default.
• W3119962057 hasAuthorship W3119962057A5040861018 @default.
• W3119962057 hasAuthorship W3119962057A5043896532 @default.
• W3119962057 hasAuthorship W3119962057A5044278014 @default.
• W3119962057 hasAuthorship W3119962057A5057833853 @default.
• W3119962057 hasAuthorship W3119962057A5057930986 @default.
• W3119962057 hasAuthorship W3119962057A5088209711 @default.
• W3119962057 hasAuthorship W3119962057A5090109122 @default.
• W3119962057 hasAuthorship W3119962057A5091509377 @default.
• W3119962057 hasBestOaLocation W31199620571 @default.
• W3119962057 hasConcept C126322002 @default.
• W3119962057 hasConcept C138885662 @default.
• W3119962057 hasConcept C15708023 @default.
• W3119962057 hasConcept C2779134260 @default.
• W3119962057 hasConcept C3008058167 @default.
• W3119962057 hasConcept C524204448 @default.
• W3119962057 hasConcept C71924100 @default.
• W3119962057 hasConceptScore W3119962057C126322002 @default.

• next